The European Cell & Gene Therapy Congress 2022
The European Cell and Gene Therapy Congress 2022Join Us | Booth #38
Discover our latest single-use solutions to fill your cell and gene therapy needs. They are customizable to fit into any process including cell growth, separation, mixing, and storage. We combine product innovation and quick-turn response to deliver critical solutions for your upstream and downstream operations.
Our experts will be happy to meet you on site to answer your questions! We look forward to seeing you soon.
Featured Presentation
Single-use fluoropolymer systems for biomanufacturing: from bench to clinic
WEDNESDAY, DECEMBER 7 | 15:00 – 15:30 PM
Gene Edited Ex Vivo Cell Therapy Stream
Disposable technologies are now widely accepted as gold standard in the industry covering every single step of the biomanufacturing process. This presentation examines the benefits of fluoropolymer film in a wide scope of applications (e.g., cell banking, cell and gene therapy, vaccinology, purified proteins at various scales) and will be supported with recent case studies on carefully selected molecular entities (e.g., lactalbumin) and submicron particles of biopharmaceutical interest.
Presented by Julien Muzard, field applications technologist EMEA, Entegris
Featured Poster
Fluoropolymer Single-Use Technologies to Enable New Generation of Cell and Gene Therapy
Several representative studies are presented on this poster to showcase the suitability of fluoroplymer single-use assemblies for viral vector MV, lipid nanoparticle (LNP), high-density cell banking as well as cell culture with HEK293 cells for cell and gene therapy applications.
Event Related Content
Protect and Preserve Product in Freeze/Thaw, Storage, and Shipment
Many C> treatments such as CAR-T and mRNA vaccines require repeated freezing and thawing during production, storage, and delivery. Aramus™ single-use assemblies are ideal for protecting and optimizing the cold-chain freeze/thaw processes for these precious treatments
Aramus™ single-use bag assemblies are ideal for cold chain collection and storage. Our single-layer fluoropolymer provides gamma stability with low extractables and leachables (E&L) and has a wide operating temperature range.
High-density cell banking (HDCB) intensifies the upstream process by providing a much larger volume of highly concentrated cells to start a production run. This process can shorten seed train by several weeks. HDCB allows high cell concentrations in larger volumes to be stored at -80°C for limited periods or in liquid nitrogen vapor for extended periods.
Our Life Sciences Technology Center is your gateway to cutting-edge freeze/thaw technology and support. We provide everything needed to make educated decisions about what freezing process and products best fit your needs.
Entegris, a world-class supplier of advanced materials and process solutions for the semiconductor industry, brings over 50 years of contamination control expertise and supply chain strength to life sciences customers around the world. Our technologies help improve purity and yield in a wide range of pharmaceutical applications including COVID-19 vaccine manufacturing.
Aramus™ 2D single-use bags provide high purity, exceptional compatibility, and increased safety for critical process fluids and final products. These robust products are now available in custom shapes, sizes, and assembly configurations to optimize your process.
Recorded Webinar
Seed train process intensification is becoming a common processing strategy to drive efficiency. Learn how utilizing high-density cell banking workflows in combination with your already intensified upstream process can further enhance your process productivity while reducing contamination risks.
Every source of contamination must be considered in biomanufacturing processes, drug formulation, and drug delivery. Potential sources of contamination are single-use systems (SUS) and components. Learn more about potential contamination risks and how to monitor and mitigate them.
Every source of contamination must be considered in biomanufacturing processes, drug formulation, and drug delivery. Potential sources of contamination are single-use systems (SUS) and components. Learn more about potential contamination risks and how to monitor and mitigate them.
Numerous cell and gene therapy workflows rely on the ability of the process to be halted and re-established via freezing and thawing of intermediate and final product formulations. Early process and tool decisions can help overcome future complexity and uncertainty. See how to address freeze/thaw manufacturing capacity and infrastructure challenges by working in partnership with a well-resourced freeze/thaw ecosystem center.